Senior Consultant David Cooney gives speech on the future of precision medicine
|16th March 2018
The clinical value precision medicines promises is widely recognised as the future of healthcare, but the inherent complexity of introducing these treatments and incorporating them into clinical practice is challenging for both industry and academia.
On 14 March 2018, Senior Consultant David Cooney arrived in Dublin, Ireland, to talk to key industry players about some of the challenges experienced by those developing precision medicines.
He presented an enlightening speech on ‘Understanding the opportunity of precision medicine’ at The National Pharmaceutical & Life Sciences Expo, held at the Citywest Exhibition Centre.
The presentation set out the differences between personalised and precision medicine. Importantly, David focused on the commercial challenges and opportunities for those at the forefront of innovation.
"It was really inspiring to see how advanced Ireland is in precision medicine, and how many people are taking a design thinking approach to solving complex healthcare problems"
This included, making the business case for precision medicine and exploring how the industry can help support the implementation and adoption of these innovative treatments.
He also analysed important hot topics, including the role of big data in overcoming market access challenges and delivering better patient outcomes.
More than 1,000 senior managers from the pharmaceutical and life sciences industry attended the event, taking the opportunity to learn about the latest innovations in healthcare.
David said: “It was really inspiring to see how advanced Ireland is in precision medicine, and how many people are taking a design thinking approach to solving complex healthcare problems.”
To learn more about how we support our clients in launching innovative therapies, contact david.cooney@bluelatitude.com
If you are interested in this topic, take a look at our recent articles and sign up for our newsletter here.
Blue Latitude earns an ‘outstanding’ two-star Best Companies accreditation
|13th December 2018
Blue Latitude Health is proud to announce that we have received a two-star accreditation from Best Companies after completing their accreditation survey.
Blue Latitude Health joins Fishawack Group of Companies
|10th December 2018
Blue Latitude Health announces a new partnership with Fishawack Group of Companies, fuelling our global growth.
The BLH team reveals their mo'tivation behind their Movember 'taches
|30th November 2018
We spoke to each of BLH’s 2018 Mo’bros to find out why they chose to get involved with Movember this year and support men’s health.